Fabian Aus Dem Siepen

Amyloidosis: classification, diagnosis, and treatment

Journal: Innere Medizin (Heidelberg, Germany)

Published: March 01, 2026

Endomyocardial Biopsy Revisited: Diagnostic Value and Expanding Roles in Cardiac Amyloidosis.

Journal: Current heart failure reports

Published: January 08, 2026

The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis

Published: January 08, 2026

Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis.

Journal: Cardiology and therapy

Published: November 27, 2025

Cardiac Perspective on Amyloidosis: Appropriate Cardiac Diagnostic Approaches Following Histological Amyloid Detection in Tendinopathies

Journal: Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V...

Published: November 17, 2025

Evaluation of diastolic function in hypertrophic cardiomyopathy and cardiac amyloidosis through semi-automatic assessment - a multi-center, multi-vendor cardiovascular magnetic resonance study.

Journal: Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance

Published: October 08, 2025

Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study.

Journal: Circulation. Cardiovascular imaging

Published: June 04, 2025

Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients.

Journal: Orphanet journal of rare diseases

Published: May 15, 2025

Amyloidosis: classification, diagnosis, and treatment

Amyloidosis: classification, diagnosis, and treatment

Endomyocardial Biopsy Revisited: Diagnostic Value and Expanding Roles in Cardiac Amyloidosis.

Endomyocardial Biopsy Revisited: Diagnostic Value and Expanding Roles in Cardiac Amyloidosis.

The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?

The CATCH-ATTR study: CArpal Tunnel ligament amyloid-the Clue for early identification of Hereditary or wildtype systemic ATTR amyloidosis?

Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis.

Survival in a Contemporary, Real-World, Matched Cohort of Patients with Transthyretin Amyloid Cardiomyopathy Treated vs Not Treated with Tafamidis.

Cardiac Perspective on Amyloidosis: Appropriate Cardiac Diagnostic Approaches Following Histological Amyloid Detection in Tendinopathies

Cardiac Perspective on Amyloidosis: Appropriate Cardiac Diagnostic Approaches Following Histological Amyloid Detection in Tendinopathies

Evaluation of diastolic function in hypertrophic cardiomyopathy and cardiac amyloidosis through semi-automatic assessment - a multi-center, multi-vendor cardiovascular magnetic resonance study.

Evaluation of diastolic function in hypertrophic cardiomyopathy and cardiac amyloidosis through semi-automatic assessment - a multi-center, multi-vendor cardiovascular magnetic resonance study.

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.

Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis.

Profibrotic Biomarkers Correlate with Clinical Presentation and Outcome in Cardiac Transthyretin Amyloidosis.

Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis.

Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysis.

Retrospective analysis of a patient cohort with suspicion of systemic amyloidosis, finally not confirmed

Retrospective analysis of a patient cohort with suspicion of systemic amyloidosis, finally not confirmed

Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study.

Machine Learning to Automatically Differentiate Hypertrophic Cardiomyopathy, Cardiac Light Chain, and Cardiac Transthyretin Amyloidosis: A Multicenter CMR Study.

Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients.

Progression of QRS duration - a potential surrogate marker of survival in ATTRwt amyloidosis patients.